Скачать или смотреть Trump’s Big Pharma Deal Explained: How Medicare Just Changed Drug Prices Forever

In a move that could reshape America’s healthcare system, former President Donald Trump has struck a historic deal with pharmaceutical giants Eli Lilly and Novo Nordisk — the makers of popular weight-loss drugs like Ozempic and Wegovy.

This new agreement could slash drug prices for millions of Americans under Medicare, marking one of the biggest healthcare shifts in decades. But what’s really behind this deal? Is it a genuine reform — or a strategic play in the ongoing battle between Big Pharma, politics, and public demand?

In this video, we break down:
✅ What Trump’s Medicare-Pharma deal actually means for U.S. citizens
✅ How weight-loss drugs became a $100-billion global industry
✅ Why Eli Lilly and Novo Nordisk agreed to negotiate
✅ The hidden policy and economic implications for America’s future

This is a deep, unbiased look at U.S. healthcare, politics, and economics — explained clearly for global audiences.

If you’re interested in U.S. policy, global economics, or political analysis, make sure to subscribe and turn on notifications. We bring you real stories, real data, and real insight — without faces, without bias.

trump pharma deal, medicare drug prices, eli lilly, novo nordisk, ozempic, wegovy, trump news 2025, big pharma reform, u.s. healthcare, trump medicare policy, american politics news, global economics, weight loss drugs usa, trump healthcare reform, drug price cuts, cnn political news, usa current affairs, faceless news channel

#TrumpNews #BigPharma #Medicare #USPolitics #HealthcareReform #EliLilly #NovoNordisk #Ozempic #Wegovy #DrugPrices #USANews #PoliticalAnalysis #GlobalEconomics